HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ammad Ahmad Farooqi Selected Research

MicroRNAs (MicroRNA)

6/2022Interplay between Non-coding RNAs and NRF2 in Different Cancers: Spotlight on miRNAs and Long non-coding RNAs.
5/2022Regulation of ROCK1/2 by long non-coding RNAs and circular RNAs in different cancer types.
1/2022Regulation of cell signaling pathways by circular RNAs and microRNAs in different cancers: Spotlight on Wnt/β-catenin, JAK/STAT, TGF/SMAD, SHH/GLI, NOTCH and Hippo pathways.
1/2022Regulatory effects of noncoding RNAs on the interplay of oxidative stress and autophagy in cancer malignancy and therapy.
1/2022Interaction of long non-coding RNAs and circular RNAs with microRNAs for the regulation of immunological responses in human cancers.
1/2021Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer.
12/2020Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis.
10/2020Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways.
9/2020Piceatannol mediated regulation of deregulated signaling pathways in different cancers: Tumbling of the ninepins of molecular oncology.
6/2020TRAIL mediated signaling as a double-edged sword in pancreatic cancer: Analysis of brighter and darker sides of the pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ammad Ahmad Farooqi Research Topics

Disease

120Neoplasms (Cancer)
06/2022 - 01/2011
18Prostatic Neoplasms (Prostate Cancer)
01/2018 - 12/2010
15Neoplasm Metastasis (Metastasis)
06/2022 - 09/2014
15Carcinogenesis
06/2022 - 01/2011
14Breast Neoplasms (Breast Cancer)
01/2022 - 12/2012
9Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 01/2014
6Mouth Neoplasms (Oral Cancer)
03/2022 - 07/2017
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 10/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2014
4Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 01/2014
3Squamous Cell Carcinoma of Head and Neck
01/2019 - 01/2014
3Ataxia Telangiectasia (Louis Bar Syndrome)
10/2015 - 10/2012
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2022 - 06/2015
2Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 01/2022
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 02/2019
2Lung Neoplasms (Lung Cancer)
09/2021 - 01/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2020
2Laryngeal Neoplasms (Laryngeal Cancer)
01/2019 - 12/2017
2Liver Neoplasms (Liver Cancer)
10/2018 - 03/2016
2Glioma (Gliomas)
02/2018 - 01/2018
2Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2017 - 06/2013
1Hypersensitivity (Allergy)
12/2022

Drug/Important Bio-Agent (IBA)

48MicroRNAs (MicroRNA)IBA
06/2022 - 10/2012
35Proteins (Proteins, Gene)FDA Link
06/2022 - 02/2013
15CateninsIBA
01/2022 - 12/2018
12Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2013
12Pharmaceutical PreparationsIBA
10/2021 - 04/2011
9PhytochemicalsIBA
06/2022 - 01/2011
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2010
9Apoptosis Regulatory ProteinsIBA
12/2020 - 09/2014
9Biological ProductsIBA
07/2019 - 01/2014
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2019 - 10/2013
9LigandsIBA
10/2018 - 06/2012
7RNA (Ribonucleic Acid)IBA
05/2022 - 09/2014
7Death Domain ReceptorsIBA
10/2019 - 02/2013
6Circular RNAIBA
06/2022 - 12/2020
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 12/2018
5Therapeutic UsesIBA
06/2020 - 12/2010
5ProteomeIBA
09/2017 - 04/2011
4AntioxidantsIBA
06/2022 - 10/2015
4Annexin A5IBA
03/2022 - 07/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 11/2014
4Superoxides (Superoxide)IBA
03/2022 - 08/2019
4TNF-Related Apoptosis-Inducing LigandIBA
10/2019 - 10/2014
4Messenger RNA (mRNA)IBA
07/2019 - 12/2017
4ResveratrolIBA
02/2019 - 01/2014
3Androgen Receptors (Androgen Receptor)IBA
04/2022 - 01/2014
3EnzymesIBA
01/2022 - 11/2011
3Peptides (Polypeptides)IBA
11/2021 - 09/2018
3Long Noncoding RNAIBA
03/2021 - 12/2018
3ethyl acetateIBA
01/2021 - 07/2019
3Matrix Metalloproteinases (MMPs)IBA
08/2020 - 10/2018
3Acetylcysteine (Siran)FDA LinkGeneric
08/2020 - 08/2019
3AndrogensIBA
09/2017 - 12/2010
2cytidylyl-(3'-5')-cytidine (CpC)IBA
12/2022 - 03/2022
2cryptocaryoneIBA
12/2022 - 03/2022
2Transforming Growth Factor beta (TGF-beta)IBA
06/2022 - 02/2018
28-Hydroxy-2'-DeoxyguanosineIBA
03/2022 - 09/2019
2CaspasesIBA
03/2022 - 02/2022
2Caspase 3 (Caspase-3)IBA
02/2022 - 09/2019
2Mechanistic Target of Rapamycin Complex 2IBA
11/2021 - 01/2019
2Mechanistic Target of Rapamycin Complex 1IBA
11/2021 - 01/2019
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2021 - 09/2018
2CucurbitacinsIBA
01/2021 - 10/2015
2Untranslated RNA (Noncoding RNA)IBA
01/2021 - 12/2018
2CytokinesIBA
10/2020 - 01/2016
25- (6'- triphenylphosphoniumhexyl)- 5,6- dihydro- 6- phenyl- 3,8- phenanthridinediammineIBA
08/2020 - 09/2019
2MethyltransferasesIBA
04/2020 - 01/2015
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
04/2019 - 09/2014
2KisspeptinsIBA
03/2019 - 01/2016
2Histone Deacetylase InhibitorsIBA
02/2019 - 02/2018
2Cisplatin (Platino)FDA LinkGeneric
02/2019 - 10/2018
2QuercetinIBA
12/2018 - 01/2014
2ApigeninIBA
10/2018 - 10/2015
2Antineoplastic Agents (Antineoplastics)IBA
09/2018 - 10/2014
2Telomerase (Telomerase Reverse Transcriptase)IBA
04/2018 - 12/2017
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
10/2015 - 12/2010
2CurcuminIBA
10/2015 - 01/2014
2Platelet-Derived Growth FactorIBA
07/2015 - 12/2014
1dihydrochalconeIBA
12/2022
1thymoquinoneIBA
06/2022
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
06/2022
1Plant ExtractsIBA
06/2022
1HMGB1 Protein (HMG1)IBA
03/2022
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
03/2022
1berbamine (penduline)IBA
03/2022
1Caspase 9IBA
02/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1ChromatinIBA
01/2022
1Nucleosomes (Nucleosome)IBA
01/2022
1N-methyladenosineIBA
01/2022
1MelatoninIBA
01/2022
1SaponinsIBA
11/2021
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
11/2021
1SincalideFDA Link
11/2021

Therapy/Procedure

42Therapeutics
05/2022 - 09/2011
5Precision Medicine
12/2020 - 10/2012
3Drug Therapy (Chemotherapy)
10/2018 - 09/2014
2Immunomodulation
01/2022 - 09/2021
1Chemoprevention
06/2022